Abstract
Periodontitis is a chronic inflammatory disease characterized by the destruction of tooth-supporting tissues. Neutrophils are critical players in this process, often becoming hyper-responsive and driving bone loss. This study investigated the protective effects of D-mannose on chronic periodontitis using a rat model of lipopolysaccharide (LPS)-induced inflammation. Results showed that D-mannose treatment significantly reduced alveolar bone resorption and suppressed the expression of pro-inflammatory cytokines (IL-1β, IL-6, IL-17, and TNF-α) while upregulating the anti-inflammatory cytokine IL-10. Mechanistically, D-mannose inhibited neutrophil recruitment and activation, likely by downregulating key glycolytic enzymes (HK1, HK2, PFKFB3) and the epigenetic regulator TET2. These findings suggest that D-mannose may serve as a novel therapeutic agent for managing periodontal disease by modulating neutrophil metabolism and function.
Introduction
Chronic periodontitis is a widespread inflammatory condition that leads to the progressive destruction of the periodontium and eventual tooth loss. While the disease is initiated by microbial biofilms, the subsequent tissue damage is largely mediated by an overzealous host immune response. Neutrophils, as the primary innate immune cells in the gingival crevice, play a dual role: they are essential for controlling infection but can also cause significant collateral damage when hyper-activated.
D-mannose, a natural C-2 epimer of glucose, has recently gained attention for its anti-inflammatory properties. It has been shown to modulate T-cell differentiation and macrophage polarization in other disease models. This study explores whether D-mannose can mitigate the severity of periodontitis by "reining in" overactive neutrophils and shifting their metabolic and epigenetic profiles.
Methods and Materials
The researchers established a rat model of periodontitis by injecting lipopolysaccharide (LPS) into the gingival tissues. Sprague Dawley rats were divided into three groups: Control, LPS, and LPS + D-mannose (administered via oral gavage).
Assessment of Bone Loss
Alveolar bone resorption was quantified using micro-CT scanning to measure the Bone Volume/Total Volume (BV/TV) ratio and the distance between the cementoenamel junction and the alveolar bone crest (CEJ-ABC). Histological analysis was performed using H&E and methylene blue staining to visualize tissue architecture and bone levels.
Molecular Profiling
To understand the underlying mechanisms, the team performed RT-PCR and Western Blotting to assess the expression of pro-inflammatory (IL-1β, IL-6, IL-17, TNF-α) and anti-inflammatory (IL-10) cytokines. They also tracked the expression of key glycolytic enzymes (HK1, HK2, PFKFB3) and the epigenetic enzyme TET2 (Ten-eleven translocation 2).
Neutrophil Analysis
Primary neutrophils were isolated from rat peripheral blood for in vitro mechanistic studies. The researchers used immunofluorescence (IF) and flow cytometry to track neutrophil recruitment and activation markers, such as Myeloperoxidase (MPO) and Ly6G.
Key Insights
Metabolic Reprogramming of Neutrophils
A central finding of this study is that inflammatory neutrophils are "fueled" by glycolysis. D-mannose appears to interfere with this metabolic pathway. Because D-mannose is taken up by the same transporters as glucose but accumulates as mannose-6-phosphate, it essentially "clogs" the glycolytic engine. This reduces the neutrophil's capacity to produce inflammatory signals and reactive oxygen species.
The TET2-Glycolysis Connection
The study highlights a potential crosstalk between metabolism and epigenetics. TET2, an enzyme typically associated with DNA demethylation, saw its expression spike during periodontitis but was suppressed by D-mannose. This suggests that metabolic changes (glycolytic inhibition) influence epigenetic states (TET2 downregulation) to drive the anti-inflammatory effect.
Results
Preservation of Alveolar Bone
Micro-CT analysis confirmed that D-mannose treatment significantly mitigated bone loss. Rats receiving D-mannose showed a higher BV/TV ratio and a reduced CEJ-ABC distance compared to the LPS-only group. Histological staining corroborated these findings, showing preserved trabecular bone and reduced inflammatory cell infiltration in the D-mannose group.
Suppression of the Inflammatory Cascade
D-mannose treatment led to a marked decrease in the mRNA and protein levels of major pro-inflammatory markers, including IL-1β, IL-6, IL-17, and TNF-α. Conversely, the expression of the anti-inflammatory cytokine IL-10 was significantly upregulated, suggesting a shift toward a more balanced immune state.
Inhibition of Neutrophil Recruitment and Activation
Immunofluorescence staining revealed a significant reduction in the number of Ly6G-positive (mature) and MPO-positive (activated) neutrophils in the gingival tissues of D-mannose-treated rats. In vitro results confirmed that D-mannose directly inhibits the activation of neutrophils stimulated by LPS.
Discussion and Conclusion
This study demonstrates that D-mannose can alleviate chronic periodontitis in rats by regulating neutrophil functions. By targeting the metabolic "engine" of these cells and influencing epigenetic regulators like TET2, D-mannose offers a novel, safe, and potentially effective therapeutic strategy for managing periodontal inflammation. While further research is needed to translate these findings to human clinical settings, D-mannose represents a promising candidate for adjunctive periodontal therapy.
Summary updated